Add Yahoo as a preferred source to see more of our stories on Google. The musical stylings of woodwinds, brass, percussions and more will come to Fuqua Park during a summer concert series beginning ...

A pill has been found to almost double the survival time for advanced pancreatic cancer patients, with experts describing the trial as a game changer. The drug, called daraxonrasib, appears to be a ...

WASHINGTON — A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of long-needed better treatments for one of the deadliest types of ...

At last week's meeting of top cancer researchers, there was big news. It's a new drug that researchers say is redefining treatment of pancreatic cancer, a disease once thought to be virtually ...

CHICAGO, May 31 (Reuters) - Revolution Medicine's (RVMD.O), opens new tab experimental pancreatic cancer pill doubled survival compared with chemotherapy and improved symptoms enough that some ...

Experts hail daraxonrasib as ‘gamechanger’ for patients with advanced pancreatic cancer A daily pill can double survival time in patients with the world’s deadliest cancer, according to the results of ...

An experimental pancreatic cancer drug has ignited hope in a field desperate for new treatments. Compared with traditional chemotherapy, a pill called daraxonrasib nearly doubled the survival time of ...

A pancreatic cancer drug more than four decades in the making has cracked one of the most stubbornly lethal cancers, extending people’s lives and keeping their tumors in check for twice as long as ...

An experimental drug from Revolution Medicines has proven broadly effective against an aggressive and tough-to-treat pancreatic tumor in a highly anticipated study result that could quickly change ...

Britain’s Got Talent fans weren’t happy with judge Alesha Dixon as she took to the stage with her former band Mis-Teeq. Britain’s Got Talent returned tonight, Saturday, May 30, for the last time this ...

A virus has stopped pancreatic cancer in its tracks in three people in a clinical trial in the US. Further evaluation is needed in larger trials, but the early results are encouraging, especially ...